Definitions

Sorry, no definitions found. Check out and contribute to the discussion of this word!

Etymologies

Sorry, no etymologies found.

Support

Help support Wordnik (and make this page ad-free) by adopting the word laronidase.

Examples

  • Then, in November, the US Food and Drug Administration warned of the potential for foreign particle contamination in all lots of the two aforementioned therapies plus Myozyme (alglucosidase alpha) for Pompe disease, Aldurazyme (laronidase) for mucopolysaccharidosis type I and Thyrogen (thyrotropin alpha) for thyroid cancer.

    PharmaTimes World News 2010

  • In November, the US Food and Drug Administration warned of the potential for foreign particle contamination in all lots of the four aforementioned therapies plus Aldurazyme (laronidase) for mucopolysaccharidosis type I and Thyrogen (thyrotropin alpha) for thyroid cancer.

    PharmaTimes World News 2010

  • Aldurazyme (R) (laronidase) for MPS I is manufactured by BioMarin and marketed by Genzyme Corporation.

    BioSpace.com Featured News and Stories 2010

  • In this role, Dr. Meeker oversaw the successful global launches of Aldurazyme® (laronidase), Fabrazyme® (agalsidase beta) and Myozyme® (alglucosidase alfa).

    StreetInsider.com News Articles 2010

  • Aldurazyme (R) (laronidase) for MPS I is manufactured by BioMarin and marketed by Genzyme Corporation.

    unknown title 2009

  • Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt

    unknown title 2011

  • (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation;

    BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease - Yahoo! Finance 2011

  • (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation;

    RedOrbit News - Technology 2010

  • (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation;

    BioSpace.com Featured News and Stories 2010

  • (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation;

    Medindia Health News 2010

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.